Enteral Feeding Formulas Market by Type (Polymeric Formulas, Monomeric Formulas, Blenderized Foods, Formulas for Specific Metabolic Needs, Immune Enhancing Formulas, Modular Formulas, Hydration Solutions); by Stage (Adult, Children); By Application (Oncology, Gastroenterology, Neurology, Diabetes, Others); by End Users (Hospitals, Long-Term Care { Nursing Homes, Homecare Agencies, Assisted Living Facilities}); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Supply, Demand, Comparative Analysis, Trends and Forecast, 2018-2026

Report ID :AMI-44 | Category : Healthcare | Published Date :June, 2018 | Pages : 309 | Format :PDF
Buy Now!

Industry Trends

Nutritional support is considered as a vital component in medical care. Enteral nutrition (EN) is provision of nutrients via the gastrointestinal (GI) tract through a feeding tube, catheter or stoma. It is the preferred route for the provision of nutrition for patients who cannot meet their nutrition needs through voluntary oral intake. This type of feeding provides many physiologic, metabolic, safety, and cost benefits over other methods of feeding. Enteral nutrition is preferred as a route of administration for nutritional support when gastrointestinal tract is functional. Compared to the conventional central venous feeding, enteral feeding is associated with fewer serious complications. It helps in better nutrient absorption and facilitates better metabolic activities. In addition, delivery of nutrients by GI tract allows decreased risk of septic, risk of cholestasis and stimulates dozens of gut peptides. Although enteral feeding techniques existed since ancient times, most of the developments in enteral feeding techniques took place during the 20th century. Commercial products with chemically defined feeding formulas were introduced in 1950s, while the development of modern formulas took place in 1970s.

Enteral Feeding Formulas Market, By Region, 2018 – 2026, (USD Million)

Enteral Feeding Formulas Market

The selection of an enteral formula must be patient specific. The functioning and capacity of the GI tract, underlying disease states and patient tolerance must be assessed to determine which formula should be selected. In terms of revenue, the global enteral feeding formulas market was US$ 4680 Mn in 2017 and is estimated to be US$ 6710 Mn by 2022.

Enteral Feeding Formulas Market, by Stage

At present, the adult sub segment is leading the market. Enteral nutrition in adults is prescribed when an individual is not capable for oral intake of food. For instance, in dysphagia or reduced level of consciousness, oral intake is not adequate to meet nutritional requirements in adults. At that time, enteral nutrition has proved to be safe, cost effective, and compatible with the body’s normal processes. Enteral feeding formulas are used in adults suffering from various health related conditions. They are used for patients suffering from severe acute pancreatitis, high output proximal fistula, intractable vomiting or diarrhea and others. Many a times due to major injuries, individuals get bedridden. Even if an individual undergoes major surgeries of throat and stomach lining, he is not allowed to consume food orally. At, such times eternal feeding formulas are prescribed by doctors.

Enteral Feeding Formulas Market, by Region

The region of North America is on the forefront as compared to others during the forecast year 2018-2026, owing to increasing number of citizens residing in the United States, suffering from severe esophagus related conditions and widespread awareness about enteral feeding devices. The American Cancer Society estimated that people suffering from esophageal cancer in the United States for the year 2018 is 17,290. The number has been increasing since 2010. The affected people are mostly advised to opt for enteral feeding as their digestion system remains weak which restricts them from taking anything orally.

Competitive Landscape

The enteral feeding formulas market report provides both, qualitative and quantitative research of the market, as well as strategic insights along with developments that are being adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisition (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.

Enteral feeding formulas market participants include Nestlé S.A., Mead Johnson & Company, LLC, Danone S.A., Fresenius Kabi A, B. Braun Melsungen AG, Global Health Products, Inc., Victus, Inc., Abbott Laboratories, Meiji Holdings Co., Ltd, Hormel Foods, LLC, Byram Healthcare, Medline Industries Inc, Nutritional Medicinals, LLC, NUTRICIA, Real Food Blends, HOIL BIOMAED INC. amongst others. Nestlé Health Science announced the launch of its new and improved product ‘Compleat’ family of tube-feeding formulas for adults and children in 2017. The improved product now includes a variety of ingredients from real foods, vitamins, minerals, and other nutrients.

Enteral Feeding Formulas Market Background

Enteral Feeding Formulas Market Enteral Feeding Formulas Market

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Enteral Feeding Formulas Market Snapshot

3.    Executive Summary: Enteral Feeding Formulas Market

4.    Qualitative Analysis: Enteral Feeding Formulas Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    Global Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Market Revenue (US$ Mn) and Forecasts

5.2.   Global Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

5.2.1.   Polymeric Formulas

5.2.1.1.    Definition

5.2.1.2.    Market Penetration

5.2.1.3.    Market Revenue Expected to Increase by 2026

5.2.1.4.    Compound Annual Growth Rate (CAGR)

5.2.2.   Monomeric Formulas

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.2.3.   Blenderized Foods

5.2.3.1.    Definition

5.2.3.2.    Market Penetration

5.2.3.3.    Market Revenue Expected to Increase by 2026

5.2.3.4.    Compound Annual Growth Rate (CAGR)

5.2.4.   Formulas for Specific Metabolic Needs

5.2.4.1.    Definition

5.2.4.2.    Market Penetration

5.2.4.3.    Market Revenue Expected to Increase by 2026

5.2.4.4.    Compound Annual Growth Rate (CAGR)

5.2.5.   Immune Enhancing Formulas

5.2.5.1.    Definition

5.2.5.2.    Market Penetration

5.2.5.3.    Market Revenue Expected to Increase by 2026

5.2.5.4.    Compound Annual Growth Rate (CAGR)

5.2.6.   Modular Formulas

5.2.6.1.    Definition

5.2.6.2.    Market Penetration

5.2.6.3.    Market Revenue Expected to Increase by 2026

5.2.6.4.    Compound Annual Growth Rate (CAGR)

5.2.7.   Hydration Solutions

5.2.7.1.    Definition

5.2.7.2.    Market Penetration

5.2.7.3.    Market Revenue Expected to Increase by 2026

5.2.7.4.    Compound Annual Growth Rate (CAGR)

5.3.   Key Segment for Channeling Investments

5.3.1.   By Type

6.    Global Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

6.2.1.   Adult

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Children

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Stage

7.    Global Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.2.   Global Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

7.2.1.   Oncology

7.2.1.1.    Definition

7.2.1.2.    Market Penetration

7.2.1.3.    Market Revenue Expected to Increase by 2026

7.2.1.4.    Compound Annual Growth Rate (CAGR)

7.2.2.   Gastroenterology

7.2.2.1.    Definition

7.2.2.2.    Market Penetration

7.2.2.3.    Market Revenue Expected to Increase by 2026

7.2.2.4.    Compound Annual Growth Rate (CAGR)

7.2.3.   Neurology

7.2.3.1.    Definition

7.2.3.2.    Market Penetration

7.2.3.3.    Market Revenue Expected to Increase by 2026

7.2.3.4.    Compound Annual Growth Rate (CAGR)

7.2.4.   Diabetes

7.2.4.1.    Definition

7.2.4.2.    Market Penetration

7.2.4.3.    Market Revenue Expected to Increase by 2026

7.2.4.4.    Compound Annual Growth Rate (CAGR)

7.2.5.   Others

7.2.5.1.    Definition

7.2.5.2.    Market Penetration

7.2.5.3.    Market Revenue Expected to Increase by 2026

7.2.5.4.    Compound Annual Growth Rate (CAGR)

7.3.   Key Segment for Channeling Investments

7.3.1.   By Application

8.    Global Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.2.   Global Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

8.2.1.   Hospitals

8.2.1.1.    Definition

8.2.1.2.    Market Penetration

8.2.1.3.    Market Revenue Expected to Increase by 2026

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.2.    Long-Term Care (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Nursing Homes, Homecare Agencies, Assisted Living Facilities)

8.2.2.1.    Nursing Homes

8.2.2.2.    Homecare Agencies

8.2.2.3.    Assisted Living Facilities

8.3.   Key Segment for Channeling Investments

8.3.1.   By End Users

9.    North America Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   North America Market Revenue (US$ Mn)

9.2.   North America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

9.2.1.   Polymeric Formulas

9.2.2.   Monomeric Formulas

9.2.3.   Blenderized Foods

9.2.4.   Formulas for Specific Metabolic Needs

9.2.5.   Immune Enhancing Formulas

9.2.6.   Modular Formulas

9.2.7.   Hydration Solutions

9.3.   North America Market Revenue (US$ Mn) and Forecasts, By Stage

9.3.1.   Adult

9.3.2.   Children

9.4.   North America Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.   Oncology

9.4.2.   Gastroenterology

9.4.3.   Neurology

9.4.4.   Diabetes

9.4.5.   Others

9.5.   North America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

9.5.1.   Hospitals

9.5.2.    Long-Term Care

9.5.2.1.    Nursing Homes

9.5.2.2.    Homecare Agencies

9.5.2.3.    Assisted Living Facilities

9.6.   North America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Country

9.6.1.   U.S.

9.6.1.1.    U.S. Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

9.6.1.1.1.    Polymeric Formulas

9.6.1.1.2.    Monomeric Formulas

9.6.1.1.3.    Blenderized Foods

9.6.1.1.4.    Formulas for Specific Metabolic Needs

9.6.1.1.5.    Immune Enhancing Formulas

9.6.1.1.6.    Modular Formulas

9.6.1.1.7.    Hydration Solutions

9.6.1.2.    U.S. Market Revenue (US$ Mn) and Forecasts, By Stage

9.6.1.2.1.    Adult

9.6.1.2.2.    Children

9.6.1.3.    U.S. Market Revenue (US$ Mn) and Forecasts, By Application

9.6.1.3.1.    Oncology

9.6.1.3.2.    Gastroenterology

9.6.1.3.3.    Neurology

9.6.1.3.4.    Diabetes

9.6.1.3.5.    Others

9.6.1.4.    U.S. Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

9.6.1.4.1.    Hospitals

9.6.1.4.2.     Long-Term Care

9.6.1.4.2.1.  Nursing Homes

9.6.1.4.2.2.  Homecare Agencies

9.6.1.4.2.3.  Assisted Living Facilities

9.6.2.   Rest of North America

9.6.2.1.    Rest of North America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

9.6.2.1.1.    Polymeric Formulas

9.6.2.1.2.    Monomeric Formulas

9.6.2.1.3.    Blenderized Foods

9.6.2.1.4.    Formulas for Specific Metabolic Needs

9.6.2.1.5.    Immune Enhancing Formulas

9.6.2.1.6.    Modular Formulas

9.6.2.1.7.    Hydration Solutions

9.6.2.2.    Rest of North America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

9.6.2.2.1.    Adult

9.6.2.2.2.    Children

9.6.2.3.    Rest of North America Market Revenue (US$ Mn) and Forecasts, By Application

9.6.2.3.1.    Oncology

9.6.2.3.2.    Gastroenterology

9.6.2.3.3.    Neurology

9.6.2.3.4.    Diabetes

9.6.2.3.5.    Others

9.6.2.4.    Rest of North America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

9.6.2.4.1.    Hospitals

9.6.2.4.2.     Long-Term Care

9.6.2.4.2.1.  Nursing Homes

9.6.2.4.2.2.  Homecare Agencies

9.6.2.4.2.3.  Assisted Living Facilities

9.7.   Key Segment for Channeling Investments

9.7.1.   By Country

9.7.2.   By Type

9.7.3.   By Stage

9.7.4.   By Application

9.7.5.   By End Users

10. Europe Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Europe Market Revenue (US$ Mn)

10.2. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.2.1. Polymeric Formulas

10.2.2. Monomeric Formulas

10.2.3. Blenderized Foods

10.2.4. Formulas for Specific Metabolic Needs

10.2.5. Immune Enhancing Formulas

10.2.6. Modular Formulas

10.2.7. Hydration Solutions

10.3. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

10.3.1. Adult

10.3.2. Children

10.4. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1. Oncology

10.4.2. Gastroenterology

10.4.3. Neurology

10.4.4. Diabetes

10.4.5. Others

10.5. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

10.5.1. Hospitals

10.5.2.  Long-Term Care

10.5.2.1.  Nursing Homes

10.5.2.2.  Homecare Agencies

10.5.2.3.  Assisted Living Facilities

10.6. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Country

10.6.1. France

10.6.1.1.  France Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.6.1.1.1.  Polymeric Formulas

10.6.1.1.2.  Monomeric Formulas

10.6.1.1.3.  Blenderized Foods

10.6.1.1.4.  Formulas for Specific Metabolic Needs

10.6.1.1.5.  Immune Enhancing Formulas

10.6.1.1.6.  Modular Formulas

10.6.1.1.7.  Hydration Solutions

10.6.1.2.  France Market Revenue (US$ Mn) and Forecasts, By Stage

10.6.1.2.1.  Adult

10.6.1.2.2.  Children

10.6.1.3.  France Market Revenue (US$ Mn) and Forecasts, By Application

10.6.1.3.1.  Oncology

10.6.1.3.2.  Gastroenterology

10.6.1.3.3.  Neurology

10.6.1.3.4.  Diabetes

10.6.1.3.5.  Others

10.6.1.4.  France Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

10.6.1.4.1.  Hospitals

10.6.1.4.2.   Long-Term Care

10.6.1.4.2.1.  Nursing Homes

10.6.1.4.2.2.  Homecare Agencies

10.6.1.4.2.3.  Assisted Living Facilities

10.6.2. The UK

10.6.2.1.  The UK Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.6.2.1.1.  Polymeric Formulas

10.6.2.1.2.  Monomeric Formulas

10.6.2.1.3.  Blenderized Foods

10.6.2.1.4.  Formulas for Specific Metabolic Needs

10.6.2.1.5.  Immune Enhancing Formulas

10.6.2.1.6.  Modular Formulas

10.6.2.1.7.  Hydration Solutions

10.6.2.2.  The UK Market Revenue (US$ Mn) and Forecasts, By Stage

10.6.2.2.1.  Adult

10.6.2.2.2.  Children

10.6.2.3.  The UK Market Revenue (US$ Mn) and Forecasts, By Application

10.6.2.3.1.  Oncology

10.6.2.3.2.  Gastroenterology

10.6.2.3.3.  Neurology

10.6.2.3.4.  Diabetes

10.6.2.3.5.  Others

10.6.2.4.  The UK Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

10.6.2.4.1.  Hospitals

10.6.2.4.2.   Long-Term Care

10.6.2.4.2.1.  Nursing Homes

10.6.2.4.2.2.  Homecare Agencies

10.6.2.4.2.3.  Assisted Living Facilities

10.6.3. Spain

10.6.3.1.  Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.6.3.1.1.  Polymeric Formulas

10.6.3.1.2.  Monomeric Formulas

10.6.3.1.3.  Blenderized Foods

10.6.3.1.4.  Formulas for Specific Metabolic Needs

10.6.3.1.5.  Immune Enhancing Formulas

10.6.3.1.6.  Modular Formulas

10.6.3.1.7.  Hydration Solutions

10.6.3.2.  Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

10.6.3.2.1.  Adult

10.6.3.2.2.  Children

10.6.3.3.  Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

10.6.3.3.1.  Oncology

10.6.3.3.2.  Gastroenterology

10.6.3.3.3.  Neurology

10.6.3.3.4.  Diabetes

10.6.3.3.5.  Others

10.6.3.4.  Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

10.6.3.4.1.  Hospitals

10.6.3.4.2.   Long-Term Care

10.6.3.4.2.1.  Nursing Homes

10.6.3.4.2.2.  Homecare Agencies

10.6.3.4.2.3.  Assisted Living Facilities

10.6.4. Germany

10.6.4.1.  Germany Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.6.4.1.1.  Polymeric Formulas

10.6.4.1.2.  Monomeric Formulas

10.6.4.1.3.  Blenderized Foods

10.6.4.1.4.  Formulas for Specific Metabolic Needs

10.6.4.1.5.  Immune Enhancing Formulas

10.6.4.1.6.  Modular Formulas

10.6.4.1.7.  Hydration Solutions

10.6.4.2.  Germany Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

10.6.4.2.1.  Adult

10.6.4.2.2.  Children

10.6.4.3.  Germany Market Revenue (US$ Mn) and Forecasts, By Application

10.6.4.3.1.  Oncology

10.6.4.3.2.  Gastroenterology

10.6.4.3.3.  Neurology

10.6.4.3.4.  Diabetes

10.6.4.3.5.  Others

10.6.4.4.  Germany Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

10.6.4.4.1.  Hospitals

10.6.4.4.2.   Long-Term Care

10.6.4.4.2.1.  Nursing Homes

10.6.4.4.2.2.  Homecare Agencies

10.6.4.4.2.3.  Assisted Living Facilities

10.6.5. Italy

10.6.5.1.  Italy Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.6.5.1.1.  Polymeric Formulas

10.6.5.1.2.  Monomeric Formulas

10.6.5.1.3.  Blenderized Foods

10.6.5.1.4.  Formulas for Specific Metabolic Needs

10.6.5.1.5.  Immune Enhancing Formulas

10.6.5.1.6.  Modular Formulas

10.6.5.1.7.  Hydration Solutions

10.6.5.2.  Italy Market Revenue (US$ Mn) and Forecasts, By Stage

10.6.5.2.1.  Adult

10.6.5.2.2.  Children

10.6.5.3.  Italy Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

10.6.5.3.1.  Oncology

10.6.5.3.2.  Gastroenterology

10.6.5.3.3.  Neurology

10.6.5.3.4.  Diabetes

10.6.5.3.5.  Others

10.6.5.4.  Italy Market Revenue (US$ Mn) and Forecasts, By End Users

10.6.5.4.1.  Hospitals

10.6.5.4.2.   Long-Term Care

10.6.5.4.2.1.  Nursing Homes

10.6.5.4.2.2.  Homecare Agencies

10.6.5.4.2.3.  Assisted Living Facilities

10.6.6. Rest of Europe

10.6.6.1.  Rest of Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

10.6.6.1.1.  Polymeric Formulas

10.6.6.1.2.  Monomeric Formulas

10.6.6.1.3.  Blenderized Foods

10.6.6.1.4.  Formulas for Specific Metabolic Needs

10.6.6.1.5.  Immune Enhancing Formulas

10.6.6.1.6.  Modular Formulas

10.6.6.1.7.  Hydration Solutions

10.6.6.2.  Rest of Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

10.6.6.2.1.  Adult

10.6.6.2.2.  Children

10.6.6.3.  Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.6.6.3.1.  Oncology

10.6.6.3.2.  Gastroenterology

10.6.6.3.3.  Neurology

10.6.6.3.4.  Diabetes

10.6.6.3.5.  Others

10.6.6.4.  Rest of Europe Market Revenue (US$ Mn) and Forecasts, By End Users

10.6.6.4.1.  Hospitals

10.6.6.4.2.   Long-Term Care

10.6.6.4.2.1.  Nursing Homes

10.6.6.4.2.2.  Homecare Agencies

10.6.6.4.2.3.  Assisted Living Facilities

10.7. Key Segment for Channeling Investments

10.7.1. By Country

10.7.2. By Type

10.7.3. By Stage

10.7.4. By Application

10.7.5. By End Users

11. Asia Pacific  Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Asia Pacific Market Revenue (US$ Mn)

11.2. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

11.2.1. Polymeric Formulas

11.2.2. Monomeric Formulas

11.2.3. Blenderized Foods

11.2.4. Formulas for Specific Metabolic Needs

11.2.5. Immune Enhancing Formulas

11.2.6. Modular Formulas

11.2.7. Hydration Solutions

11.3. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Stage

11.3.1. Adult

11.3.2. Children

11.4. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1. Oncology

11.4.2. Gastroenterology

11.4.3. Neurology

11.4.4. Diabetes

11.4.5. Others

11.5. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.1. Hospitals

11.5.2.  Long-Term Care

11.5.2.1.  Nursing Homes

11.5.2.2.  Homecare Agencies

11.5.2.3.  Assisted Living Facilities

11.6. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Country

11.6.1. China

11.6.1.1.  China Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

11.6.1.1.1.  Polymeric Formulas

11.6.1.1.2.  Monomeric Formulas

11.6.1.1.3.  Blenderized Foods

11.6.1.1.4.  Formulas for Specific Metabolic Needs

11.6.1.1.5.  Immune Enhancing Formulas

11.6.1.1.6.  Modular Formulas

11.6.1.1.7.  Hydration Solutions

11.6.1.2.  China Market Revenue (US$ Mn) and Forecasts, By Stage

11.6.1.2.1.  Adult

11.6.1.2.2.  Children

11.6.1.3.  China Market Revenue (US$ Mn) and Forecasts, By Application

11.6.1.3.1.  Oncology

11.6.1.3.2.  Gastroenterology

11.6.1.3.3.  Neurology

11.6.1.3.4.  Diabetes

11.6.1.3.5.  Others

11.6.1.4.  China Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

11.6.1.4.1.  Hospitals

11.6.1.4.2.   Long-Term Care

11.6.1.4.2.1.  Nursing Homes

11.6.1.4.2.2.  Homecare Agencies

11.6.1.4.2.3.  Assisted Living Facilities

11.6.2. Japan

11.6.2.1.  Japan Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

11.6.2.1.1.  Polymeric Formulas

11.6.2.1.2.  Monomeric Formulas

11.6.2.1.3.  Blenderized Foods

11.6.2.1.4.  Formulas for Specific Metabolic Needs

11.6.2.1.5.  Immune Enhancing Formulas

11.6.2.1.6.  Modular Formulas

11.6.2.1.7.  Hydration Solutions

11.6.2.2.  Japan Market Revenue (US$ Mn) and Forecasts, By Stage

11.6.2.2.1.  Adult

11.6.2.2.2.  Children

11.6.2.3.  Japan Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

11.6.2.3.1.  Oncology

11.6.2.3.2.  Gastroenterology

11.6.2.3.3.  Neurology

11.6.2.3.4.  Diabetes

11.6.2.3.5.  Others

11.6.2.4.  Japan Market Revenue (US$ Mn) and Forecasts, By End Users

11.6.2.4.1.  Hospitals

11.6.2.4.2.   Long-Term Care

11.6.2.4.2.1.  Nursing Homes

11.6.2.4.2.2.  Homecare Agencies

11.6.2.4.2.3.  Assisted Living Facilities

11.6.3. India

11.6.3.1.  India Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

11.6.3.1.1.  Polymeric Formulas

11.6.3.1.2.  Monomeric Formulas

11.6.3.1.3.  Blenderized Foods

11.6.3.1.4.  Formulas for Specific Metabolic Needs

11.6.3.1.5.  Immune Enhancing Formulas

11.6.3.1.6.  Modular Formulas

11.6.3.1.7.  Hydration Solutions

11.6.3.2.  India Market Revenue (US$ Mn) and Forecasts, By Stage

11.6.3.2.1.  Adult

11.6.3.2.2.  Children

11.6.3.3.  India Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

11.6.3.3.1.  Oncology

11.6.3.3.2.  Gastroenterology

11.6.3.3.3.  Neurology

11.6.3.3.4.  Diabetes

11.6.3.3.5.  Others

11.6.3.4.  India Market Revenue (US$ Mn) and Forecasts, By End Users

11.6.3.4.1.  Hospitals

11.6.3.4.2.   Long-Term Care

11.6.3.4.2.1.  Nursing Homes

11.6.3.4.2.2.  Homecare Agencies

11.6.3.4.2.3.  Assisted Living Facilities

11.6.4. Southeast Asia

11.6.4.1.  Southeast Asia Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

11.6.4.1.1.  Polymeric Formulas

11.6.4.1.2.  Monomeric Formulas

11.6.4.1.3.  Blenderized Foods

11.6.4.1.4.  Formulas for Specific Metabolic Needs

11.6.4.1.5.  Immune Enhancing Formulas

11.6.4.1.6.  Modular Formulas

11.6.4.1.7.  Hydration Solutions

11.6.4.2.  Southeast Asia Market Revenue (US$ Mn) and Forecasts, By Stage

11.6.4.2.1.  Adult

11.6.4.2.2.  Children

11.6.4.3.  Southeast Asia Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

11.6.4.3.1.  Oncology

11.6.4.3.2.  Gastroenterology

11.6.4.3.3.  Neurology

11.6.4.3.4.  Diabetes

11.6.4.3.5.  Others

11.6.4.4.  Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End Users

11.6.4.4.1.  Hospitals

11.6.4.4.2.   Long-Term Care

11.6.4.4.2.1.  Nursing Homes

11.6.4.4.2.2.  Homecare Agencies

11.6.4.4.2.3.  Assisted Living Facilities

11.6.5. Rest of Asia Pacific

11.6.5.1.  Rest of Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

11.6.5.1.1.  Polymeric Formulas

11.6.5.1.2.  Monomeric Formulas

11.6.5.1.3.  Blenderized Foods

11.6.5.1.4.  Formulas for Specific Metabolic Needs

11.6.5.1.5.  Immune Enhancing Formulas

11.6.5.1.6.  Modular Formulas

11.6.5.1.7.  Hydration Solutions

11.6.5.2.  Rest of Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Stage

11.6.5.2.1.  Adult

11.6.5.2.2.  Children

11.6.5.3.  Rest of Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Application

11.6.5.3.1.  Oncology

11.6.5.3.2.  Gastroenterology

11.6.5.3.3.  Neurology

11.6.5.3.4.  Diabetes

11.6.5.3.5.  Others

11.6.5.4.  Rest of Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

11.6.5.4.1.  Hospitals

11.6.5.4.2.   Long-Term Care

11.6.5.4.2.1.  Nursing Homes

11.6.5.4.2.2.  Homecare Agencies

11.6.5.4.2.3.  Assisted Living Facilities

11.7. Key Segment for Channeling Investments

11.7.1. By Country

11.7.2. By Type

11.7.3. By Stage

11.7.4. By Application

11.7.5. By End Users

12. Middle East and Africa Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Middle East and Africa Market Revenue (US$ Mn)

12.2. Middle East and Africa Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

12.2.1. Polymeric Formulas

12.2.2. Monomeric Formulas

12.2.3. Blenderized Foods

12.2.4. Formulas for Specific Metabolic Needs

12.2.5. Immune Enhancing Formulas

12.2.6. Modular Formulas

12.2.7. Hydration Solutions

12.3. Middle East and Africa Market Revenue (US$ Mn) and Forecasts, By Stage

12.3.1. Adult

12.3.2. Children

12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Oncology

12.4.2. Gastroenterology

12.4.3. Neurology

12.4.4. Diabetes

12.4.5. Others

12.5. Middle East and Africa Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.1. Hospitals

12.5.2.  Long-Term Care

12.5.2.1.  Nursing Homes

12.5.2.2.  Homecare Agencies

12.5.2.3.  Assisted Living Facilities

12.6. Middle East and Africa Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. GCC Countries

12.6.1.1.  GCC Countries Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

12.6.1.1.1.  Polymeric Formulas

12.6.1.1.2.  Monomeric Formulas

12.6.1.1.3.  Blenderized Foods

12.6.1.1.4.  Formulas for Specific Metabolic Needs

12.6.1.1.5.  Immune Enhancing Formulas

12.6.1.1.6.  Modular Formulas

12.6.1.1.7.  Hydration Solutions

12.6.1.2.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Stage

12.6.1.2.1.  Adult

12.6.1.2.2.  Children

12.6.1.3.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.3.1.  Oncology

12.6.1.3.2.  Gastroenterology

12.6.1.3.3.  Neurology

12.6.1.3.4.  Diabetes

12.6.1.3.5.  Others

12.6.1.4.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.1.4.1.  Hospitals

12.6.1.4.2.   Long-Term Care

12.6.1.4.2.1.  Nursing Homes

12.6.1.4.2.2.  Homecare Agencies

12.6.1.4.2.3.  Assisted Living Facilities

12.6.2. Southern Africa

12.6.2.1.  Southern Africa Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

12.6.2.1.1.  Polymeric Formulas

12.6.2.1.2.  Monomeric Formulas

12.6.2.1.3.  Blenderized Foods

12.6.2.1.4.  Formulas for Specific Metabolic Needs

12.6.2.1.5.  Immune Enhancing Formulas

12.6.2.1.6.  Modular Formulas

12.6.2.1.7.  Hydration Solutions

12.6.2.2.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By Stage

12.6.2.2.1.  Adult

12.6.2.2.2.  Children

12.6.2.3.  Southern Africa Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.3.1.  Oncology

12.6.2.3.2.  Gastroenterology

12.6.2.3.3.  Neurology

12.6.2.3.4.  Diabetes

12.6.2.3.5.  Others

12.6.2.4.  Southern Africa Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.2.4.1.  Hospitals

12.6.2.4.2.   Long-Term Care

12.6.2.4.2.1.  Nursing Homes

12.6.2.4.2.2.  Homecare Agencies

12.6.2.4.2.3.  Assisted Living Facilities

12.6.3. Rest of MEA

12.6.3.1.  Rest of MEA Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

12.6.3.1.1.  Polymeric Formulas

12.6.3.1.2.  Monomeric Formulas

12.6.3.1.3.  Blenderized Foods

12.6.3.1.4.  Formulas for Specific Metabolic Needs

12.6.3.1.5.  Immune Enhancing Formulas

12.6.3.1.6.  Modular Formulas

12.6.3.1.7.  Hydration Solutions

12.6.3.2.  Rest of MEA Market Revenue (US$ Mn) and Forecasts, By Stage

12.6.3.2.1.  Adult

12.6.3.2.2.  Children

12.6.3.3.  Rest of MEA Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.3.1.  Oncology

12.6.3.3.2.  Gastroenterology

12.6.3.3.3.  Neurology

12.6.3.3.4.  Diabetes

12.6.3.3.5.  Others

12.6.3.4.  Rest of MEA Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.3.4.1.  Hospitals

12.6.3.4.2.   Long-Term Care

12.6.3.4.2.1.  Nursing Homes

12.6.3.4.2.2.  Homecare Agencies

12.6.3.4.2.3.  Assisted Living Facilities

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Type

12.7.3. By Stage

12.7.4. By Application

12.7.5. By End Users

13. Latin America Enteral Feeding Formulas Market Analysis and Forecasts, 2018 – 2026

13.1. Overview

13.1.1. Latin America Market Revenue (US$ Mn)

13.2. Latin America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

13.2.1. Polymeric Formulas

13.2.2. Monomeric Formulas

13.2.3. Blenderized Foods

13.2.4. Formulas for Specific Metabolic Needs

13.2.5. Immune Enhancing Formulas

13.2.6. Modular Formulas

13.2.7. Hydration Solutions

13.3. Latin America Market Revenue (US$ Mn) and Forecasts, By Stage

13.3.1. Adult

13.3.2. Children

13.4. Latin America Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Oncology

13.4.2. Gastroenterology

13.4.3. Neurology

13.4.4. Diabetes

13.4.5. Others

13.5. Latin America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.1. Hospitals

13.5.2.  Long-Term Care

13.5.2.1.  Nursing Homes

13.5.2.2.  Homecare Agencies

13.5.2.3.  Assisted Living Facilities

13.6. Latin America Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. Brazil

13.6.1.1.  Brazil Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

13.6.1.1.1.  Polymeric Formulas

13.6.1.1.2.  Monomeric Formulas

13.6.1.1.3.  Blenderized Foods

13.6.1.1.4.  Formulas for Specific Metabolic Needs

13.6.1.1.5.  Immune Enhancing Formulas

13.6.1.1.6.  Modular Formulas

13.6.1.1.7.  Hydration Solutions

13.6.1.2.  Brazil Market Revenue (US$ Mn) and Forecasts, By Stage

13.6.1.2.1.  Adult

13.6.1.2.2.  Children

13.6.1.3.  Brazil Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.3.1.  Oncology

13.6.1.3.2.  Gastroenterology

13.6.1.3.3.  Neurology

13.6.1.3.4.  Diabetes

13.6.1.3.5.  Others

13.6.1.4.  Brazil Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.1.4.1.  Hospitals

13.6.1.4.2.   Long-Term Care

13.6.1.4.2.1.  Nursing Homes

13.6.1.4.2.2.  Homecare Agencies

13.6.1.4.2.3.  Assisted Living Facilities

13.6.2. Rest of Latin America

13.6.2.1.  Rest of Latin America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Type

13.6.2.1.1.  Polymeric Formulas

13.6.2.1.2.  Monomeric Formulas

13.6.2.1.3.  Blenderized Foods

13.6.2.1.4.  Formulas for Specific Metabolic Needs

13.6.2.1.5.  Immune Enhancing Formulas

13.6.2.1.6.  Modular Formulas

13.6.2.1.7.  Hydration Solutions

13.6.2.2.  Rest of Latin America Market Revenue (US$ Mn) and Forecasts, By Stage

13.6.2.2.1.  Adult

13.6.2.2.2.  Children

13.6.2.3.  Rest of Latin America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.3.1.  Oncology

13.6.2.3.2.  Gastroenterology

13.6.2.3.3.  Neurology

13.6.2.3.4.  Diabetes

13.6.2.3.5.  Others

13.6.2.4.  Rest of Latin America Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.2.4.1.  Hospitals

13.6.2.4.2.   Long-Term Care

13.6.2.4.2.1.  Nursing Homes

13.6.2.4.2.2.  Homecare Agencies

13.6.2.4.2.3.  Assisted Living Facilities

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Type

13.7.3. By Stage

13.7.4. By Application

13.7.5. By End Users

14. Competitive Benchmarking

14.1. Player Positioning Analysis

14.2. Global Presence and Growth Strategies

15. Player Profiles

15.1. Abbott Laboratories

15.1.1. Company Details

15.1.2. Company Overview

15.1.3. Product Offerings

15.1.4. Key Developments

15.1.5. Financial Analysis

15.1.6. SWOT Analysis

15.1.7. Business Strategies

15.2. B. Braun Melsungen AG

15.2.1. Company Details

15.2.2. Company Overview

15.2.3. Product Offerings

15.2.4. Key Developments

15.2.5. Financial Analysis

15.2.6. SWOT Analysis

15.2.7. Business Strategies

15.3. Byram Healthcare

15.3.1. Company Details

15.3.2. Company Overview

15.3.3. Product Offerings

15.3.4. Key Developments

15.3.5. Financial Analysis

15.3.6. SWOT Analysis

15.3.7. Business Strategies

15.4. Danone S.A

15.4.1. Company Details

15.4.2. Company Overview

15.4.3. Product Offerings

15.4.4. Key Developments

15.4.5. Financial Analysis

15.4.6. SWOT Analysis

15.4.7. Business Strategies

15.5. Fresenius Kabi A

15.5.1. Company Details

15.5.2. Company Overview

15.5.3. Product Offerings

15.5.4. Key Developments

15.5.5. Financial Analysis

15.5.6. SWOT Analysis

15.5.7. Business Strategies

15.6. Global Health Products, Inc.

15.6.1. Company Details

15.6.2. Company Overview

15.6.3. Product Offerings

15.6.4. Key Developments

15.6.5. Financial Analysis

15.6.6. SWOT Analysis

15.6.7. Business Strategies

15.7. Hormel Foods, LLC

15.7.1. Company Details

15.7.2. Company Overview

15.7.3. Product Offerings

15.7.4. Key Developments

15.7.5. Financial Analysis

15.7.6. SWOT Analysis

15.7.7. Business Strategies

15.8. HOIL BIOMAED INC.

15.8.1. Company Details

15.8.2. Company Overview

15.8.3. Product Offerings

15.8.4. Key Developments

15.8.5. Financial Analysis

15.8.6. SWOT Analysis

15.8.7. Business Strategies

15.9. Mead Johnson & Company, LLC

15.9.1. Company Details

15.9.2. Company Overview

15.9.3. Product Offerings

15.9.4. Key Developments

15.9.5. Financial Analysis

15.9.6. SWOT Analysis

15.9.7. Business Strategies

15.10. Meiji Holdings Co., Ltd

15.10.1.  Company Details

15.10.2.  Company Overview

15.10.3.  Product Offerings

15.10.4.  Key Developments

15.10.5.  Financial Analysis

15.10.6.  SWOT Analysis

15.10.7.  Business Strategies

15.11. Medline Industries Inc

15.11.1.  Company Details

15.11.2.  Company Overview

15.11.3.  Product Offerings

15.11.4.  Key Developments

15.11.5.  Financial Analysis

15.11.6.  SWOT Analysis

15.11.7.  Business Strategies

15.12. Nestlé S.A.

15.12.1.  Company Details

15.12.2.  Company Overview

15.12.3.  Product Offerings

15.12.4.  Key Developments

15.12.5.  Financial Analysis

15.12.6.  SWOT Analysis

15.12.7.  Business Strategies

15.13. Nutritional Medicinals, LLC

15.13.1.  Company Details

15.13.2.  Company Overview

15.13.3.  Product Offerings

15.13.4.  Key Developments

15.13.5.  Financial Analysis

15.13.6.  SWOT Analysis

15.13.7.  Business Strategies

15.14. NUTRICIA

15.14.1.  Company Details

15.14.2.  Company Overview

15.14.3.  Product Offerings

15.14.4.  Key Developments

15.14.5.  Financial Analysis

15.14.6.  SWOT Analysis

15.14.7.  Business Strategies

15.15. Real Food Blends

15.15.1.  Company Details

15.15.2.  Company Overview

15.15.3.  Product Offerings

15.15.4.  Key Developments

15.15.5.  Financial Analysis

15.15.6.  SWOT Analysis

15.15.7.  Business Strategies

15.16. Victus, Inc.

15.16.1.  Company Details

15.16.2.  Company Overview

15.16.3.  Product Offerings

15.16.4.  Key Developments

15.16.5.  Financial Analysis

15.16.6.  SWOT Analysis

15.16.7.  Business Strategies

 

 

 Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

At Absolute Markets Insights, we use both top-down and bottom-up approach for calculating the market estimates and market forecast data. We allocate year-on-year growth rate from 2018 to 2026 and reach to the calculations for the global CAGR. Basically for estimation of the products and applications, usually we follow bottom-up approach, where we track the trends in different regions and their countries. We track down the growth factors, restraints, rules & regulations and opportunities for each country  and its region and finally calculate the global numbers. We first track the growth for the U.S. and Rest of North America. With these factors we can estimate the growth and trend for North America, similar approach would be taken for Europe, Asia Pacific, Latin America and Middle East & Africa. Finally, through our home grown model we reach to estimation and forecasting of the global numbers.   

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends. 

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

 

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 204

    Backtrace:

    File: /home/absolute/public_html/application/views/pages/reportpage.php
    Line: 204
    Function: _error_handler

    File: /home/absolute/public_html/application/controllers/Report.php
    Line: 153
    Function: view

    File: /home/absolute/public_html/index.php
    Line: 315
    Function: require_once